Repeated resection of colorectal liver metastases

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The expansion of resection of colorectal hepatic metastases over the past two decades has been accompanied by a concomitant expansion of nonresectional options to treat patients with liver-only colorectal metastases. Comparative outcomes for different therapeutic strategies are largely unavailable or incomplete. Without sufficient equipoise to randomize the disparate population of patients with hepatic recurrence to all available therapeutic options, we will likely need to individualize our treatment strategies without the use of randomized trials. Clarifying the role of repeated hepatectomy for patients with recurrent disease requires knowledge of the outcomes, limitations, and alternatives for repeated resection of colorectal metastases. In this review, consideration of the published experience with hepatic re-resection can help define the boundaries and expectations for patient selection and outcomes.

Original languageEnglish (US)
Pages (from-to)211-217
Number of pages7
JournalCurrent Colorectal Cancer Reports
Volume10
Issue number2
DOIs
StatePublished - 2014

Fingerprint

Neoplasm Metastasis
Liver
Hepatectomy
Patient Selection
Therapeutics
Recurrence
Population
boldenone undecylenate

Keywords

  • Colorectal liver metastases
  • Hepatectomy
  • Liver resection
  • Recurrent colorectal metastases
  • Repeat liver resection

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology
  • Hepatology

Cite this

Repeated resection of colorectal liver metastases. / Mansour, John C.

In: Current Colorectal Cancer Reports, Vol. 10, No. 2, 2014, p. 211-217.

Research output: Contribution to journalArticle

@article{5ba06f17a18c4b98a5af9cb176cb88aa,
title = "Repeated resection of colorectal liver metastases",
abstract = "The expansion of resection of colorectal hepatic metastases over the past two decades has been accompanied by a concomitant expansion of nonresectional options to treat patients with liver-only colorectal metastases. Comparative outcomes for different therapeutic strategies are largely unavailable or incomplete. Without sufficient equipoise to randomize the disparate population of patients with hepatic recurrence to all available therapeutic options, we will likely need to individualize our treatment strategies without the use of randomized trials. Clarifying the role of repeated hepatectomy for patients with recurrent disease requires knowledge of the outcomes, limitations, and alternatives for repeated resection of colorectal metastases. In this review, consideration of the published experience with hepatic re-resection can help define the boundaries and expectations for patient selection and outcomes.",
keywords = "Colorectal liver metastases, Hepatectomy, Liver resection, Recurrent colorectal metastases, Repeat liver resection",
author = "Mansour, {John C.}",
year = "2014",
doi = "10.1007/s11888-014-0216-7",
language = "English (US)",
volume = "10",
pages = "211--217",
journal = "Current Colorectal Cancer Reports",
issn = "1556-3790",
publisher = "Springer Science + Business Media",
number = "2",

}

TY - JOUR

T1 - Repeated resection of colorectal liver metastases

AU - Mansour, John C.

PY - 2014

Y1 - 2014

N2 - The expansion of resection of colorectal hepatic metastases over the past two decades has been accompanied by a concomitant expansion of nonresectional options to treat patients with liver-only colorectal metastases. Comparative outcomes for different therapeutic strategies are largely unavailable or incomplete. Without sufficient equipoise to randomize the disparate population of patients with hepatic recurrence to all available therapeutic options, we will likely need to individualize our treatment strategies without the use of randomized trials. Clarifying the role of repeated hepatectomy for patients with recurrent disease requires knowledge of the outcomes, limitations, and alternatives for repeated resection of colorectal metastases. In this review, consideration of the published experience with hepatic re-resection can help define the boundaries and expectations for patient selection and outcomes.

AB - The expansion of resection of colorectal hepatic metastases over the past two decades has been accompanied by a concomitant expansion of nonresectional options to treat patients with liver-only colorectal metastases. Comparative outcomes for different therapeutic strategies are largely unavailable or incomplete. Without sufficient equipoise to randomize the disparate population of patients with hepatic recurrence to all available therapeutic options, we will likely need to individualize our treatment strategies without the use of randomized trials. Clarifying the role of repeated hepatectomy for patients with recurrent disease requires knowledge of the outcomes, limitations, and alternatives for repeated resection of colorectal metastases. In this review, consideration of the published experience with hepatic re-resection can help define the boundaries and expectations for patient selection and outcomes.

KW - Colorectal liver metastases

KW - Hepatectomy

KW - Liver resection

KW - Recurrent colorectal metastases

KW - Repeat liver resection

UR - http://www.scopus.com/inward/record.url?scp=84903739500&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903739500&partnerID=8YFLogxK

U2 - 10.1007/s11888-014-0216-7

DO - 10.1007/s11888-014-0216-7

M3 - Article

AN - SCOPUS:84903739500

VL - 10

SP - 211

EP - 217

JO - Current Colorectal Cancer Reports

JF - Current Colorectal Cancer Reports

SN - 1556-3790

IS - 2

ER -